STK31 activators can be described as a collection of chemical compounds that, either directly or indirectly, influence the activity of the serine/threonine kinase STK31. The diversity of these chemicals reflects the intricate nature of cellular kinase signaling, with various pathways being intricately interwoven. Chemicals such as Forskolin and Dibutyryl-cAMP, which modulate cAMP levels or mimic its effects, showcase the importance of cyclic nucleotide signaling in regulating STK31 activity. This regulation is further emphasized by 8-Br-cGMP, underscoring the significance of cyclic nucleotide pathways.
Calcium signaling, a cornerstone in cellular processes, is represented by agents like Ionomycin and A23187. These compounds, by altering intracellular calcium levels, can play a role in the activity modulation of calcium-responsive kinases, and STK31. Additionally, compounds like EGF and Insulin, well-known for their roles in initiating broad kinase cascades, can have a cascade effect that may involve STK31. In the realm of kinase-phosphatase balance, Okadaic Acid emerges as a prominent figure, where its inhibition of protein phosphatases can lead to heightened kinase activity. PMA and Anisomycin both dive into specific kinase pathways, highlighting the intertwined nature of cellular kinase networks. Lastly, U0126 and LY294002, by targeting critical nodes like MEK and PI3K respectively, provide insight into the broader kinase landscapes where STK31 operates.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, raising cAMP levels which can activate protein kinase A (PKA) pathways, potentially influencing STK31. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular calcium levels, potentially influencing calcium-dependent kinases and STK31 activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
By initiating the insulin signaling pathway, it may indirectly influence kinases like STK31. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates Protein Kinase C (PKC) which could intersect with STK31 signaling pathways. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibitor of protein phosphatases PP1 and PP2A, potentially elevating kinase activity including STK31. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates JNK signaling, which could interact with or influence STK31 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that raises intracellular calcium, potentially affecting kinases like STK31. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Analog of cAMP; can activate cAMP-dependent pathways potentially influencing STK31. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor; by modulating PI3K-AKT pathway, it might indirectly influence STK31. | ||||||
8-Bromo-cGMP | 51116-01-9 | sc-200316 sc-200316A | 10 mg 50 mg | $104.00 $354.00 | 7 | |
Analog of cGMP; can activate cGMP-dependent pathways potentially affecting STK31. | ||||||